oxidopamine has been researched along with Hemisensory Neglect in 7 studies
Oxidopamine: A neurotransmitter analogue that depletes noradrenergic stores in nerve endings and induces a reduction of dopamine levels in the brain. Its mechanism of action is related to the production of cytolytic free-radicals.
oxidopamine : A benzenetriol that is phenethylamine in which the hydrogens at positions 2, 4, and 5 on the phenyl ring are replaced by hydroxy groups. It occurs naturally in human urine, but is also produced as a metabolite of the drug DOPA (used for the treatment of Parkinson's disease).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients suffering from Parkinson's disease (PD) display cognitive and neuropsychiatric dysfunctions, especially with disease progression." | 1.43 | Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease. ( Dunnett, SB; Kelly, CM; Lelos, MJ; Morgan, RJ; Rosser, AE; Torres, EM, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lelos, MJ | 1 |
| Morgan, RJ | 1 |
| Kelly, CM | 1 |
| Torres, EM | 2 |
| Rosser, AE | 1 |
| Dunnett, SB | 3 |
| Heuer, A | 1 |
| Henderson, JM | 2 |
| Watson, S | 1 |
| Halliday, GM | 1 |
| Heinemann, T | 1 |
| Gerlach, M | 1 |
| Watson, SH | 1 |
| Eslamboli, A | 1 |
| Georgievska, B | 1 |
| Ridley, RM | 1 |
| Baker, HF | 1 |
| Muzyczka, N | 1 |
| Burger, C | 1 |
| Mandel, RJ | 1 |
| Annett, L | 1 |
| Kirik, D | 1 |
| Castañeda, E | 1 |
| Fleming, S | 1 |
| Paquette, MA | 1 |
| Boat, K | 1 |
| Moffett, J | 1 |
| Stachowiak, EK | 1 |
| Bloom, DC | 1 |
| Stachowiak, MK | 1 |
| Dowd, E | 1 |
| Monville, C | 1 |
7 other studies available for oxidopamine and Hemisensory Neglect
| Article | Year |
|---|---|
Amelioration of non-motor dysfunctions after transplantation of human dopamine neurons in a model of Parkinson's disease.
Topics: Animals; Calbindins; Cognition Disorders; Disease Models, Animal; Dopaminergic Neurons; Female; Fetu | 2016 |
Characterisation of spatial neglect induced by unilateral 6-OHDA lesions on a choice reaction time task in rats.
Topics: Amphetamine; Animals; Attention; Central Nervous System Stimulants; Choice Behavior; Disease Models, | 2013 |
Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat.
Topics: Animals; Apomorphine; Behavior, Animal; Cell Death; Disease Models, Animal; Dopamine; Female; Functi | 2003 |
Convulsive and postural effects of lesioning the mid-substantia nigra pars reticulata in naïve and 6-hydroxydopamine lesioned rats.
Topics: Animals; Apomorphine; Behavior, Animal; Cortical Synchronization; Disease Models, Animal; Dopamine A | 2003 |
Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease.
Topics: Animals; Appetitive Behavior; Callithrix; Choice Behavior; Dependovirus; Disease Models, Animal; Dop | 2005 |
Assessment of recovery in the hemiparkinson rat: drug-induced rotation is inadequate.
Topics: Animals; Apomorphine; Astrocytes; Behavioral Research; Brain Tissue Transplantation; Corpus Striatum | 2005 |
The Corridor Task: a simple test of lateralised response selection sensitive to unilateral dopamine deafferentation and graft-derived dopamine replacement in the striatum.
Topics: Animals; Corpus Striatum; Dopamine; Feeding Behavior; Female; Functional Laterality; Medial Forebrai | 2005 |